ARYX
ARYx Therapeutics, Inc.
Set alert
0.00 USD 0.00 0.00%
0.000001 Day range 0.0005
0.000001 52-week range 0.0005
- YTD
- 0.00%
- 1 year
- 0.00%
- Open
- 0.0005
- Prev close
- 0.0005
- Mkt cap
- 16.73K
- Vol
- 2.00K
- Avg vol
- 1.84K
- EPS
- -0.62
- P/E
- -0.00
More statistics
- Low
- 0.000001
- High
- 0.0005
Financial health
Altman Z-Score
-56.87 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
1 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
Valuation
P/E -2.7×
FY 2003 5y median -1.8× FY 2009
P/S 0.0×
FY 2003 5y median 1.7× FY 2009
P/B -30.2×
FY 2003 5y median -0.1× FY 2009
P/FCF -2.5×
FY 2003 5y median -1.6× FY 2009
EV/EBITDA -3.1×
FY 2003 5y median -0.9× FY 2009
EV/Sales 0.0×
FY 2003 5y median 0.0× FY 2009
FCF Yield -39.9%
FY 2003 5y median -62.8% FY 2009
Profitability
Gross Margin 0.0%
FY 2003 5y median 55.3% FY 2009
Operating Margin 0.0%
FY 2003 5y median -154.2% FY 2009
Net Margin 0.0%
FY 2003 5y median -158.3% FY 2009
ROE 1137.4%
FY 2003 5y median 29.2% FY 2009
ROIC 0.0%
FY 2003 5y median -48.2% FY 2009
ROA -267.3%
FY 2003 5y median -61.0% FY 2009
Growth (YoY)
Revenue -100.0%
FY 2003 FY 2009
Operating Income -2.7%
FY 2003 FY 2009
EPS (diluted) 26.7%
FY 2003 FY 2009
Free Cash Flow 23.4%
FY 2003 FY 2009
Financial Health
Current Ratio 1.0×
FY 2003 5y median 4.2× FY 2009
Quick Ratio 1.0×
FY 2003 5y median 4.2× FY 2009
Debt / Equity -4.1×
FY 2003 5y median -0.1× FY 2009
Net Debt / EBITDA -0.1×
FY 2003 5y median 0.3× FY 2009
Interest Coverage -15.6×
FY 2003 5y median -21.3× FY 2009
Dividends
Dividend Yield 0.0%
FY 2003 5y median 0.0% FY 2009
Payout Ratio 0.0%
FY 2003 5y median 0.0% FY 2009
Annual · latest fiscal year ends 2009-12-31